A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Nandrolone phenpropionate
Dihydroergocristine
Cholic Acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.
Nandrolone phenpropionate
Pilsicainide
Cholic Acid may decrease the excretion rate of Pilsicainide which could result in a higher serum level.
Nandrolone phenpropionate
Benzbromarone
Cholic Acid may decrease the excretion rate of Benzbromarone which could result in a higher serum level.
Nandrolone phenpropionate
Indocyanine green acid form
Cholic Acid may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level.
Nandrolone phenpropionate
Pitavastatin
Cholic Acid may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Nandrolone phenpropionate
Prasterone sulfate
Cholic Acid may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Nandrolone phenpropionate
Taurocholic acid
Cholic Acid may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.
Nandrolone phenpropionate
Relcovaptan
The risk or severity of adverse effects can be increased when Relcovaptan is combined with Cholic Acid.
Nandrolone phenpropionate
Buflomedil
The risk or severity of adverse effects can be increased when Buflomedil is combined with Cholic Acid.
Nandrolone phenpropionate
Linsidomine
The risk or severity of adverse effects can be increased when Linsidomine is combined with Cholic Acid.
Nandrolone phenpropionate
Cloricromen
The risk or severity of adverse effects can be increased when Cloricromen is combined with Cholic Acid.
Nandrolone phenpropionate
Picotamide
The risk or severity of adverse effects can be increased when Picotamide is combined with Cholic Acid.
Nandrolone phenpropionate
Ramatroban
The risk or severity of adverse effects can be increased when Ramatroban is combined with Cholic Acid.
Nandrolone phenpropionate
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Cholic Acid.
Nandrolone phenpropionate
Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Cholic Acid.
Nandrolone phenpropionate
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Cholic Acid.
Nandrolone phenpropionate
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Cholic Acid.
Nandrolone phenpropionate
Nitroaspirin
The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Cholic Acid.
Nandrolone phenpropionate
Ifetroban
The risk or severity of adverse effects can be increased when Ifetroban is combined with Cholic Acid.
Nandrolone phenpropionate
Sarpogrelate
The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Cholic Acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3